Apixa Tablet 2.5 mg contains Apixaban, a selective oral anticoagulant used to prevent and treat blood clots. It belongs to the class of direct Factor Xa inhibitors and works by interfering with the coagulation cascade to reduce the risk of thromboembolic events. Apixa is widely prescribed for patients at risk of stroke and systemic embolism, particularly in non-valvular atrial fibrillation, as well as for the treatment and prevention of deep vein thrombosis (DVT) and pulmonary embolism (PE).

Apixa offers several advantages over traditional anticoagulants, including predictable anticoagulant effects, fixed dosing without routine monitoring, and fewer dietary restrictions, making it a convenient and effective option for long-term management.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Indications

Apixa Tablet 2.5 mg is indicated for:

• Prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation

• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE)

• Prevention of recurrent DVT and PE

• Post-operative prophylaxis of venous thromboembolism in patients undergoing hip or knee replacement surgery

Therapeutic Class

• Oral Anticoagulant (Direct Factor Xa Inhibitor)

Pharmacology

Apixaban selectively inhibits Factor Xa, a key enzyme in the coagulation cascade responsible for converting prothrombin to thrombin. By inhibiting Factor Xa:

• It prevents thrombin generation, reducing fibrin clot formation

• It interrupts both intrinsic and extrinsic pathways of the coagulation cascade

• It does not require antithrombin for activity and has a rapid onset of action

Unlike vitamin K antagonists, Apixaban has predictable pharmacokinetics, allowing for fixed dosing without routine coagulation monitoring. It is absorbed orally with a bioavailability of approximately 50%, metabolized primarily via CYP3A4, and eliminated through both renal and fecal pathways.

Dosage and Administration

• Standard dose: 2.5 mg taken twice daily with or without food

• Special considerations: Dose adjustments may be necessary in patients with renal impairment, elderly patients, or those at increased risk of bleeding

• Swallow tablets whole with water; do not crush or chew

Note: Adherence to prescribed dosing is critical, as missed doses may increase the risk of thromboembolic events.

Drug Interactions

Apixaban may interact with:

• Strong CYP3A4 and P-glycoprotein inhibitors (e.g., ketoconazole, ritonavir) – increases bleeding risk

• Strong CYP3A4 and P-glycoprotein inducers (e.g., rifampin, carbamazepine) – may reduce efficacy

• Other anticoagulants or antiplatelet agents – increases risk of bleeding

• NSAIDs or herbal supplements (e.g., ginkgo, garlic) – may enhance bleeding risk

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Contraindications

• Active pathological bleeding

• Known hypersensitivity to Apixaban or any component of the formulation

• Severe hepatic impairment associated with coagulopathy

Side Effects

Common side effects include:

• Easy bruising

• Minor bleeding (nosebleeds, gum bleeding)

• Gastrointestinal discomfort

Serious side effects may include:

• Major bleeding events (gastrointestinal, intracranial)

• Anemia secondary to blood loss

• Hypersensitivity reactions (rare)

Precautions and Warnings

• Use with caution in patients with renal or hepatic impairment

• Monitor for signs of bleeding or hemorrhage

• Avoid sudden discontinuation, which may increase risk of thromboembolism

• No routine coagulation monitoring is required, but periodic renal and hepatic function assessment is recommended

Pregnancy and Lactation

• Pregnancy: Use only if clearly indicated; animal studies suggest potential risk

• Lactation: Safety not established; breastfeeding should be discontinued during therapy

Storage Conditions

Store in a cool, dry place, away from light and moisture. Keep out of reach of children.